125 related articles for article (PubMed ID: 28586005)
41. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma.
Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS
Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.
Zhang J; Tu K; Yang W; Li C; Yao Y; Zheng X; Liu Q
Mol Med Rep; 2014 Aug; 10(2):749-54. PubMed ID: 24858621
[TBL] [Abstract][Full Text] [Related]
43. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
[TBL] [Abstract][Full Text] [Related]
44. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
45. The regulation of SOX7 and its tumor suppressive role in breast cancer.
Stovall DB; Wan M; Miller LD; Cao P; Maglic D; Zhang Q; Stampfer MR; Liu W; Xu J; Sui G
Am J Pathol; 2013 Nov; 183(5):1645-1653. PubMed ID: 24012678
[TBL] [Abstract][Full Text] [Related]
46. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
47. Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker.
Pietrasz D; Pécuchet N; Garlan F; Didelot A; Dubreuil O; Doat S; Imbert-Bismut F; Karoui M; Vaillant JC; Taly V; Laurent-Puig P; Bachet JB
Clin Cancer Res; 2017 Jan; 23(1):116-123. PubMed ID: 27993964
[TBL] [Abstract][Full Text] [Related]
48. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
49. Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality.
Kim IK; Kim K; Lee E; Oh DS; Park CS; Park S; Yang JM; Kim JH; Kim HS; Shima DT; Kim JH; Hong SH; Cho YH; Kim YH; Park JB; Koh GY; Ju YS; Lee HK; Lee S; Kim I
J Exp Med; 2018 Mar; 215(3):963-983. PubMed ID: 29444818
[TBL] [Abstract][Full Text] [Related]
50. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
[TBL] [Abstract][Full Text] [Related]
51. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.
Guo X; Yang M; Gu H; Zhao J; Zou L
Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550
[TBL] [Abstract][Full Text] [Related]
52. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
53. SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function.
Zhang Y; Stovall DB; Wan M; Zhang Q; Chou JW; Li D; Sui G
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757932
[TBL] [Abstract][Full Text] [Related]
54. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
55. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
Ma YB; Li GX; Hu JX; Liu X; Shi BM
Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
57. Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic cancer.
Han J; Wang F; Yuan SQ; Guo Y; Zeng ZL; Li LR; Yang J; Wang DS; Liu MY; Zhao H; Liu KY; Liao JW; Zou QF; Xu RH
BMC Cancer; 2014 Sep; 14():650. PubMed ID: 25182632
[TBL] [Abstract][Full Text] [Related]
58. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of STAT1 and p21 proteins predicts pancreatic cancer progression and prognosis.
Sun Y; Yang S; Sun N; Chen J
Pancreas; 2014 May; 43(4):619-23. PubMed ID: 24658320
[TBL] [Abstract][Full Text] [Related]
60. The Expression and Prognostic Roles of MCMs in Pancreatic Cancer.
Peng YP; Zhu Y; Yin LD; Zhang JJ; Guo S; Fu Y; Miao Y; Wei JS
PLoS One; 2016; 11(10):e0164150. PubMed ID: 27695057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]